Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Capital Expenditures (2016 - 2025)

Prothena Corp Public has reported Capital Expenditures over the past 14 years, most recently at $10000.0 for Q3 2025.

  • Quarterly results put Capital Expenditures at $10000.0 for Q3 2025, up 11.11% from a year ago — trailing twelve months through Dec 2025 was $138000.0 (down 53.69% YoY), and the annual figure for FY2025 was $138000.0, down 53.69%.
  • Capital Expenditures for Q3 2025 was $10000.0 at Prothena Corp Public, down from $86000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for PRTA hit a ceiling of $1.5 million in Q4 2023 and a floor of $9000.0 in Q3 2024.
  • Median Capital Expenditures over the past 5 years was $116500.0 (2022), compared with a mean of $238055.6.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 925.83% in 2023 and later plummeted 97.96% in 2024.
  • Prothena Corp Public's Capital Expenditures stood at $319000.0 in 2021, then plummeted by 52.66% to $151000.0 in 2022, then skyrocketed by 925.83% to $1.5 million in 2023, then crashed by 97.22% to $43000.0 in 2024, then crashed by 76.74% to $10000.0 in 2025.
  • The last three reported values for Capital Expenditures were $10000.0 (Q3 2025), $86000.0 (Q2 2025), and $42000.0 (Q1 2025) per Business Quant data.